Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition.
about
Hmga2 translocation induced in skin tumorigenesis.Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization.Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.Association of Cytokeratin and Vimentin Protein in the Genesis of Transitional Cell Carcinoma of Urinary Bladder Patients.HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation.Development of Urinary Bladder Pre-Neoplasia by Schistosoma haematobium Eggs and Chemical Carcinogen in Mice.SMAD7: a timer of tumor progression targeting TGF-β signaling.Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.Use of vimentin immunocytochemical staining for evaluation of atypical cells in voided urine samples.HMGA2 expression distinguishes between different types of postpubertal testicular germ cell tumour.HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma.Risk score based on three mRNA expression predicts the survival of bladder cancer.Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties.
P2860
Q33728215-A359CA52-55C6-4997-8CEA-6563AEB8B1EFQ34682133-926A3BFE-A50C-4451-B37F-60874201CB4BQ35108555-AD768E57-75F7-4F35-A6F0-64A1744A1728Q36293637-8FA66AD6-814E-4A44-B5D2-9AC77F23E992Q36320307-223B260A-DAF5-49A0-8DE6-F26E81E208F4Q37679995-44CE14AE-8095-4C26-97D8-507A42D85ED4Q37720577-8D3F75E8-FDB1-4613-A55F-1B71294D3B5BQ38220764-2318C009-0546-4ADC-B4AF-A9507F3AD1CFQ38846357-CEA2DA41-9890-4972-AE67-B17F6165D382Q38852100-0CFE63AA-5F3D-4B23-9E43-A43529FA8D22Q39152604-2F1626FE-CAC0-444C-A85F-9CE1616CDECDQ39514230-FEC8C2F5-0986-4144-92B7-2AB3AAAF45B6Q41816648-8BD52F79-67F5-4E69-AFF9-3711046A9B74Q42125441-12F06C8E-CD3A-467C-BF2A-AEBB10AC1287Q42365349-9568ECE6-EB16-486C-A052-11BEFA605CFBQ53238642-08AB45B3-C592-4A16-9365-FC7FE3B9A8FFQ55035860-533CB4FA-248A-47F1-8700-5EF694BC72C2Q55106988-93FD126E-25F6-49EF-ADB2-AC17A7EA3B07
P2860
Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Expression of HMGA2 in bladder ...... ial-to-mesenchymal transition.
@en
Expression of HMGA2 in bladder ...... ial-to-mesenchymal transition.
@nl
type
label
Expression of HMGA2 in bladder ...... ial-to-mesenchymal transition.
@en
Expression of HMGA2 in bladder ...... ial-to-mesenchymal transition.
@nl
prefLabel
Expression of HMGA2 in bladder ...... ial-to-mesenchymal transition.
@en
Expression of HMGA2 in bladder ...... ial-to-mesenchymal transition.
@nl
P2093
P2860
P356
P1433
P1476
Expression of HMGA2 in bladder ...... ial-to-mesenchymal transition.
@en
P2093
P2860
P304
P356
10.1111/CPR.12096
P577
2014-02-26T00:00:00Z